0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

Contractor Notice: Further extension to SSP06 – Fluoxetine 40mg capsules

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 40mg capsules (SSP06). SSP06 for Fluoxetine 40mg capsules was previously expected to expire on 10th August but the revised end date has been further extended to 4th September 2020. This expiry date may be brought...

1 hour ago

Availability of Evorel products (Theramex) – Updated

Following the recent supply problems for the Evorel range of products, Theramex have provided this further update. ‘Following the acquisition of Evorel by Theramex in October 2019, we have worked tirelessly with multiple manufacturing partners to resupply the product in the UK market. Since February 2020, we have produced nearly 750,000 packs across the Evorel...

4 hours ago

Update on new flexible approaches to flu vaccination service

An update on the new flexible approaches being considered for support the provision of the flu vaccination service has been released. Contractors must note that the changes PSNC is seeking to the flu vaccination service, described in the update, have not yet been agreed and may never be agreed. On 3rd July 2020, PSNC published...

3 days ago

Medicines Safety 

Our aim is to promote and support safer practice by highlighting to pharmacy teams medication incidents that have occurred both locally and nationally. 

We hope you will feed in to this newsletter by letting us know about any significant medicines related incidents that have occurred in your workplace. By working together and sharing your learning from these incidents we can help prevent the same or similar incidents from happening again which in turn helps to protect our patients from harm.  Our Share & Learn Report Template can be found below:-  

Share & Learn Reporting Template

 

Medicines Safety Newsletters

Please see our Medicines Safety Newsletters below.  We will be sending these newsletters out quarterly so if you wish to receive them, click here to sign up to our mailing list. 

Medicines Safety Newsletter: Issue 1 - October 2017

Medicines Safety Newsletter: Issue 2 - February 2018

Medicines Safety Newsletter: Issue 3 - June 2018

Medicines Safety Newsletter: Issue 4 - January 2019

Medicines Safety Newsletter: Issue 5 - July 2019

 

 

Community Pharmacy Patient Safety Group 

The Community Pharmacy Patient Safety Group provides a forum for community pharmacy organisations to openly share and learn from each other when things go wrong, as well as from other sectors and industries and it is their Report, Learn, Act, Review principles which we at Community Pharmacy West Yorkshire actively promote.  


The group, which was originally hosted by Pharmacy Voice, aims to consider how learning from patient safety incidents can be applied across the pharmacy network and wider NHS,    and then create the opportunities and resources to do just that. Their website is an excellent resource for community pharmacy teams and has some really good information which many pharmacy teams will find useful (see the "resource hub" tab).  You can access their website here: https://pharmacysafety.org/

 

A recent focus for the group was on examining the potential safety risks associated with pharmacy delivery services. To inform the work, two members of the Patient Safety Group shadowed their delivery drivers for a day to gain a better understanding of the potential risks that can arise, to patients, their families and to delivery drivers themselves, when delivering medicines to people’s homes. The Group have used the insights gathered through this shadowing exercise to create tools which delivery drivers and pharmacy teams can use to evaluate the safety of their medicines delivery services. Read more here.

There is also a free CPD module that the group developed around patient safety in community pharmacy and the value of reporting and involving the whole team. See here.

 

 

Fire Risk with Emollient Use

Warnings about the risk of severe and fatal burns are now being extended to ALL emollients, whether paraffin-based or not.  See latest (Dec 18) MHRA guidance here.


Patients treated with emollients must be made aware of the potential fire risks associated with these products.  This includes paraffin-based emollients  (regardless of strength) AND paraffin-free emollients and includes products used for washing and showering.  

Patients who smoke or use a naked flame may cause clothing, bedding or bandages to catch fire as dressings and clothing soaked with the emollient can be easily ignited.  Community pharmacy teams have an essential role to play in advising patients not to smoke; use naked flames (or be near people who are smoking or using naked flames); or go near anything that may cause a fire while emollients are in contact with their medical dressings or clothing.

 

When dispensing/selling emollient products all patients should be advised that:

  • Emollients are an important and effective treatment for chronic dry skin conditions and people should continue to use these products. However, there is a fire risk associated with the build-up of residue on clothing and bedding and patients must take action to minimise the risk
  • Patients should be told to keep away from open or gas fires or hobs and naked flames, including candles etc. and not to smoke when using emollient products because clothing or fabric such as bedding or bandages that have been in contact with an emollient or emollient-treated skin can rapidly ignite.
  • There is a fire risk with all paraffin-containing emollients, regardless of paraffin concentration, and it also cannot be excluded with paraffin-free emollients. A similar risk may apply for other products which are applied to the skin over large body areas, or in large volumes for repeated use for more than a few days
  • Washing clothing or fabric at a high temperature may reduce emollient build-up but not totally remove it.

Warnings, including an alert symbol, are being added to packaging to provide a visual reminder to patients and those caring for them about the fire hazard.  Please also take care to ensure that any flammability warnings on the product are not covered up.

Patients should be given both verbal and written information on the potential fire risks. It is recommended that a record of information provided is kept on the PMR and communicated on regular occasions.

 

Further Resources

 
 
 
Last Updated: 31st July 2019